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Changes in gene expression during reversible bud-hypha transitions of the opportunistic fungal pathogen
Candida albicans permit adaptation to environmental conditions that are critical for proliferation in host
tissues. Our previous work has shown that the hypha-specific adhesin gene HWP1 is up-regulated by the cyclic
AMP (cAMP) signaling pathway. However, little is known about the potential influences of determinants of cell
morphology on HWP1 gene expression. We found that blocking hypha formation with cytochalasin A, which
destabilizes actin filaments, and with latrunculin A, which sequesters actin monomers, led to a loss of HWP1
gene expression. In contrast, high levels of HWP1 gene expression were observed when the F-actin stabilizer
jasplakinolide was used to block hypha formation, suggesting that HWP1 expression could be regulated by
actin structures. Mutants defective in formin-mediated nucleation of F-actin were reduced in HWP1 gene
expression, providing genetic support for the importance of actin structures. Kinetic experiments with wildtype and actin-deficient cells revealed two distinct phases of HWP1 gene expression, with a slow, actinindependent phase preceding a fast, actin-dependent phase. Low levels of HWP1 gene expression that appeared
to be independent of stabilized actin and cAMP signaling were detected using indirect immunofluorescence. A
connection between actin structures and the cAMP signaling pathway was shown using hyper- and hypomorphic cAMP mutants, providing a possible mechanism for up-regulation of HWP1 gene expression by stabilized
actin. The results reveal a new role for F-actin as a regulatory agent of hypha-specific gene expression at the
bud-hypha transition.
Candida albicans is an opportunistic fungal pathogen with a
tropism for the gastrointestinal mucosa. The progression to
candidiasis from the usual state of commensalism is prompted
by changes in the immune status of the host that relay signals
for proliferation and culminate in tissue invasion. Growth in
host tissues is characterized by the presence of yeast,
pseudohyphal, and hyphal morphologies in response to a number of environmental parameters within the host that may
include temperature, pH, and nutrition (31, 33, 66) as well as
other unknown factors. The different morphologies of C. albicans are accompanied by differences in gene expression patterns that are critical to the development of candidiasis. The
mechanisms that mediate changes in gene expression in concert with changes in morphology are directly relevant to the
regulation of virulence of C. albicans.
The hypha-specific gene HWP1 (hyphal wall protein 1) is an
attractive candidate for studying morphology-specific gene regulation since it is abundantly expressed in hyphal growth mode
and is barely detectable in the yeast morphology (73, 74).
Pseudohyphae vary in the level of HWP1 gene expression (71).
HWP1 encodes a glycosylphosphatidylinositol-linked cell wall
protein that serves as a transglutaminase substrate and enables
C. albicans to form covalent attachments to epithelial cells that
line the buccal mucosa (73, 74). Recent findings have demonstrated the presence of a critical region of the HWP1 promoter

that specifically confers developmental regulation and possesses distinct sets of protein/DNA interactions that are dependent on the morphology of the cell (29).
The regulation of HWP1 gene expression appears to be
multifaceted and involves the Cph2/Tec1, Ras/cyclic AMP
(cAMP), Bcr1/biofilm, and mitogen-activated protein kinase
signal transduction pathways to various extents depending on
growth medium (38, 39, 56, 69). A number of transcriptional
activators, including Cph1, Efg1, Tec1, Bcr1, and Flo8, and
transcriptional repressors, such as Nrg1 and Tup1, have been
shown to be critical to both hypha-specific gene expression and
hyphal development (11, 27, 54, 56, 64, 69, 79). With the
exception of BCR1 (56), the null mutant phenotypes for these
factors include aberrant growth morphologies in standard hyphal or yeast growth conditions, leaving open the possibility
that the observed phenotype of each null mutant may be indirectly mediated through unrecognized factors that accompany
morphogenesis. These findings prompt the need for experiments to investigate the possibility of a direct relationship
between the structural changes in cell shape that occur during
morphogenesis and HWP1 gene expression.
Polarization of cell growth and alterations to cytoskeletal
dynamics are both highly regulated during morphogenesis. Recent work has shown that the Rho-like GTPase Cdc42 plays a
central role in polarization and that C. albicans strains deficient for wild-type CDC42 are defective in the bud-hypha transition (50, 77). Strains carrying specific Cdc42 alterations in
residue 26, 100, or 158 have revealed roles for CDC42 in both
bud-hypha transitioning and hypha-specific gene expression
(78). In terms of the actin cytoskeleton, yeast growth is characterized by a uniform cortical distribution of F-actin patches
and cables, as shown by staining with rhodamine-conjugated
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TABLE 1. Strains used in this study
Strain

Genotype

Source or reference

SC5314
CAI4
HB-12
E-15
CKFY254
CKFY354
MWY1
SMC7A/-7B

Wild type
⌬ura3::imm434/⌬ura3::imm434
As CAI4, but with plasmid p1902GFP integrated at the HWP1 locus
As CAI4, but with plasmid pENO1GFP3 integrated at the ENO1 locus
⌬pfy1::HIS3/⌬pfy1::HIS3
⌬bnr1::URA3/⌬bnr1::URA3
As SC5314, but ⌬bni1::FRT/⌬bni1::NAT1
cdc42-1::FRT/cdc42-2::FRT ACT1/act1::FRT-CDC42-MPAR-FRT
sap2-1::PSAP2-1-ecaFLP/SAP2-2
cdc42-1::FRT/CDC42-2 ACT1/act1::FRT-CDC42-MPAR-FRT
sap2-1::PSAP2-1-ecaFLP/SAP2-2
⌬ura3/⌬ura3 cdc42::hisG/cdc42-E100G::URA3
As CAI4, but ⌬eno1::ENOp-PDE2-URA3/ENO1
As SC5314, but ⌬mea1::FRT/⌬mea1::NAT1
As SC5314, but ⌬srv2::FRT/⌬srv2::NAT1

19
17
29
72
P. Chua, Cytokinetics, Inc.
P. Chua, Cytokinetics, Inc.
This study
50

SMC8A
AV03
EPDE2-3
MWY2
MWY3

phalloidin, whereas hyphal cells concentrate F-actin at hyphal
tips (2). Extensive work with the budding yeast Saccharomyces
cerevisiae has shown that actin structures nucleated by Arp2/3
and the formins, Bni1 and Bnr1, form extensive branched networks and linear filaments, respectively, and similar findings
have been reported for yeast forms of C. albicans as well (15,
41, 46). These nucleators facilitate the localized rapid polymerization of F-actin, which allows for a high degree of regulation
in the generation of new actin filaments at specific locations in
the cell in response to the changing environment (52). The
importance of actin cytoskeletal structure and dynamics to
morphogenesis is shown by experiments in which treatment of
C. albicans cells with the microfilament destabilizer cytochalasin A prior to growth in hypha-inducing conditions results in
the complete abrogation of hyphal development while preserving cellular growth processes (1).
To better understand the regulatory connections that exist
between the cytoskeletal and membrane rearrangements of the
C. albicans bud-hypha transition and hypha-specific gene expression, we have utilized chemical-genetic and genetic approaches to analyze HWP1 expression in strains carrying a
green fluorescent protein (GFP) reporter gene. Our findings
reveal a coupling between the stability of the actin cytoskeleton
and the up-regulation of HWP1 gene expression and suggest a
new model for HWP1 regulation in which actin dynamics play
a critical role in hypha-specific gene regulation at the C. albicans bud-hypha transition.
MATERIALS AND METHODS
Strains used and growth conditions. Candida albicans was used for all experiments (Table 1). Assessments of HWP1 gene expression in a wild-type genetic
background were conducted with C. albicans strain HB-12 (29) in which
p1902GFP3, a URA3-marked plasmid containing the complete HWP1 promoter
driving GFP expression, was linearized with ClaI and integrated into the HWP1
locus of CAI4. To generate hyphae, HB-12 cells were grown for 48 h to saturation in yeast nitrogen base minimal medium. From this saturated culture, 2.5 ⫻
107 cells were inoculated into 5 ml of prewarmed Medium 199 (Invitrogen,
Carlsbad, CA) or 5 ml of yeast extract-peptone-dextrose (YPD) medium with
10% bovine calf serum (BCS) at 37°C with shaking at 100 rpm for 3 h. For
yeast-inducing conditions, the same medium conditions were used but the cells
were incubated at 30°C with shaking at 250 rpm for 3 h. In both cases, cells were
centrifuged at 4,000 rpm for 5 min following the induction period and washed
twice with phosphate-buffered saline (PBS) prior to immediate observation.
Strains CKFY254 and CKFY354 have deletions of PFY1 and BNR1, respectively, and are a gift from Penelope Chua (Cytokinetics, Inc., South San Fran-

50
78
6
This study
This study

cisco, CA). Strain SMC7A contains a conditional deletion of CDC42, whereas
strain SMC8A retains a copy of CDC42 and therefore serves as a control (50).
Strain AV03 contains one copy of CDC42, whose product has a glutamic acidto-glycine alteration at residue 100.
Nourseothricin (Werner Bioagents, Jena, Germany) was utilized for selection
in YPD medium at a concentration of 450 g/ml.
Drug treatments. The drug concentrations used for the Medium 199 experiments were as follows: cytochalasin A (Sigma-Aldrich, St. Louis, MO), 1 to 10
g/ml; latrunculin A (Invitrogen, Carlsbad, CA), 10 to 50 g/ml; jasplakinolide
(Invitrogen, Carlsbad, CA), 1 to 20 g/ml; benomyl (Sigma-Aldrich, St. Louis,
MO), 2.5 to 50 g/ml; propranolol (Sigma-Aldrich, St. Louis, MO), 125 to 175
g/ml in accordance with previous work (8); brefeldin A (Sigma-Aldrich, St.
Louis, MO), 10 to 50 g/ml; ML-7 (Sigma-Aldrich, St. Louis, MO), 10 to 50
g/ml. Drugs were dissolved in dimethyl sulfoxide as a concentrated stock solution and were added to Medium 199 or YPD plus 10% BCS at the appropriate
concentration immediately before the addition of HB-12 cells.
Three methods were used to ensure that drug treatments did not compromise
viability. First, methylene blue (0.01%, vol/vol, in PBS) staining revealed that a
minimum of 80% of the cells survived each treatment. Second, C. albicans strain
E-15, in which the constitutively active enolase promoter drives GFP expression
(72), was exposed to the maximum utilized concentration of each drug. GFP
fluorescence did not decrease after overnight exposure of E-15 to each drug
under hypha-inducing conditions. Since the estimated half-life of GFP protein in
yeast is approximately 7 h (47), the retention of GFP fluorescence was indicative
of the continued activity of essential cellular processes following drug treatment.
Third, 5 ⫻ 106 HB-12 cells were grown in Medium 199 with 10 g/ml of
cytochalasin A, latrunculin A, or jasplakinolide for 3 h at 37°C and 250-rpm
shaking. Following this incubation, the cells were washed twice and resuspended
in 10 l PBS. The cells were diluted five times at a 1:10 ratio, and all six dilutions
for each treatment were spotted onto a YPD plate. We found no difference in
growth rates among any of the drug-treated cells in comparison to untreated
control cells (data not shown).
The drug-induced effects were not growth medium dependent. Similar effects
were observed when a different growth medium (YPD plus 10% BCS) was used.
However, higher drug concentrations were required in media containing YPD
plus 10% BCS, most likely because of the enhanced growth capacity in nutritionally richer media (24, 54). Since similar results were found with both growth
media, only the results using Medium 199 are reported.
Assessment of HWP1 gene expression by fluorescence microscopy and fluorometry. Samples were processed for epifluorescence microscopy as previously
described (75). Fluorescent images were visualized with a BX-60 microscope
(Olympus, Center Valley, PA) using 600⫻ magnification and a GFP filter with
470- to 490-nm excitation and 515- to 550-nm emission. Photomicrographs of
cells expressing GFP were taken using a 7.6-second exposure with an Olympus
MagnaFire camera and processed using MagnaFire version 2.1 (Optronics, Inc.,
Goleta, CA) and Image-Pro Plus version 4.1 (Media Cybernetics, Inc., Silver
Spring, MD) software. The selected images represented the appearance of the
majority of cells in a given population.
Quantitation of fluorescence was performed using a Wallac 1420 Victor2 plate
reader (PerkinElmer, Inc., Wellesley, MA). After incubation and washing as
described above, 1.25 ⫻ 107 cells in 100 l PBS were resuspended and trans-
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TABLE 2. Oligonucleotides

Name

Sequencea (5⬘–3⬘)

Site added

BNI128N for
BNI128N rev
BNI128C for
BNI128C rev
BNI518N for
BNI518N rev
BNI518C for
BNI518C rev
NAT1 for
NAT1 rev
MEA366 for
MEA366 rev
MEA500N for
MEA500N rev
MEA500C for
MEA500C rev
MEA700N for
MEA700N rev
MEA700C for
MEA700C rev

CCCGGTACCTTGTGCCAGAAGAATACGCCAAAGTATTAATGTCA
CCTGGGCCCTTTTTTTCGTGTGATAATTCTTGGTGATAATAA
CCTCCGCGGTTGGTGGTGTTATGGATTCATTATTACAGAGGTTG
CCTGAGCTCTTTCTCTGGATCTTCTACATTACTGAAATC
GGTGGTACCTTGTATCACAAACATCTTTTCATCATCCACTACTA
GGTGGGCCCGGTTCTTTTATTTATTTATTTTTT
GGTCCGCGGGGTAAGCACTTTTTTTTGTATATGTATTTAAATGA
GGTGAGCTCGGTTGTTATCACTAAATAAACCAAAATTTGAATAC
TTCGAGCTCGTTTAAACGTCGACACTGGATGG
CAGTAGCGCCAGCGGAAGAGCAACGGGATATCAAGCTTGCCTCGTCCC
CCCGGTACCCACGCACTAACACTTAAACACACGCCC
AGGGGATCCGTACAAGACGTCCAGGTGATAGATTAT
GGTGGTACCTTTTAATAGTATTGAGTTATCCAAGAGAGTAGTGA
CCGGGGCCCAAGTTATGAAGGTATCCGTTTTTATGTCCAATAGA
GGTCCGCGGGTGAATTTGGTTTATTATAGTTTTGGTTTGATTCT
GGTGAGCTCGGTAAATCAAAATATGTTGGTTCTGGTG
GGTGGTACCTTTCGCACTAACACTTAAACACACGCCCAT
GGTGGGCCCGTACTTTTTGGTTGTTACTATATGTAAT
GGTCCGCGGGGTACTAGGGGTATAATACTTACTTTCTTCAACTT
GGTGAGCTCGGTGAATATTTGGATCAATAGCCATTGGATTA

KpnI
ApaI
SacII
SacI
KpnI
ApaI
SacII
SacI
SacI
SapI
KpnI
BamHI
KpnI
ApaI
SacII
SacI
KpnI
ApaI
SacII
SacI

a

Engineered restriction sites are in boldface.

ferred to a Falcon Microtest 96-well plate (Becton Dickinson Labware, Franklin
Lakes, NJ). Assays were performed in duplicate. Four separate readings for
optical density (OD) at 600 nm and fluorescence (485-nm excitation and 535-nm
emission) were collected for each sample. Normalization of fluorescence data
with respect to cell density was accomplished by dividing the fluorescence value
by the optical density for each individual reading.
Indirect immunofluorescence assay to detect Hwp1 and rhodamine-phalloidin
staining to detect actin. To examine Hwp1 localization, C. albicans cells grown in
hypha-inducing conditions were washed twice in ice-cold PBS and resuspended
to a concentration of 3 ⫻ 107 cells/ml. A 200-l sample of this resuspension was
placed in an Eppendorf tube, and anti-Hwp1 antibody was added at a 1:200
dilution. The cells were incubated at 37°C for 30 min with gentle shaking, washed
three times, and resuspended in 200 l of ice-cold PBS. Alexa Fluor 488 goat
anti-rabbit antibody (Molecular Probes, Eugene, OR) was then added at a 1:50
dilution, and the cells were incubated for 30 min at 37°C with gentle shaking.
After three additional washes and resuspensions in ice-cold PBS, slides were
prepared and visualized using the procedures described above for fluorescence
microscopy (75). Images were taken using a 1.2-second exposure.
Actin structures were visualized using rhodamine-phalloidin staining, which
was performed as previously described (57) using a rhodamine filter set (510- to
550-nm excitation, 570- to 590-nm emission) and a 2.4-second exposure.
Quantitation of F-actin aggregates. The total level of F-actin at the early
stages of yeast and hypha development was determined using ImageJ 1.38x
software (NIH, Bethesda, MD) in the manner previously described (28). Ten
yeast and hyphal cells were analyzed for each individual time point and statistically analyzed as described below.
Disruption of the C. albicans BNI1 gene. The BNI1 knockout strain MWY1 was
constructed using a NAT1 flipper cassette that conferred resistance to nourseothricin. Upstream and downstream regions (300 base pairs in length) of genomic
DNA relative to the BNI1 coding region were amplified using primer sets
BNI128N and BNI128C, respectively (Table 2), and genomic DNA as the template. The upstream region PCR product and pJK863, containing the NAT1
flipper cassette (70), were digested with KpnI and ApaI and gel purified
(QIAGEN, Valencia, CA). After treatment of the vector with calf intestinal
alkaline phosphatase (Fisher Scientific, Pittsburgh, PA), the two fragments were
joined using T4 DNA ligase (Invitrogen, Carlsbad, CA) and transformed into
TOP10 Escherichia coli cells (Invitrogen, Carlsbad, CA). Plasmid DNA was
purified from transformants and verified by DNA sequencing. The PCR product
corresponding to the region downstream of the BNI1 open reading frame and the
plasmid containing the upstream region were digested with SacI and SacII prior
to ligation and were transformed into TOP10 E. coli cells as described above.
The resultant BNI1 deletion cassette, pBNIDEL128, was digested with KpnI
and SacI to release the 4.2-kb flipper cassette and BNI1 flanking regions. The
cassette was recovered by gel extraction and used for electroporation of strain
SC5314 (63). Transformants were selected on YPD plates with nourseothricin

and verified by Southern blotting using EcoRV digestion and a PCR-amplified
complete genomic copy of BNI1 as the probe (not shown).
A nourseothricin-sensitive BNI1/bni1⌬ strain was created by excision of the
NAT1 cassette using standard techniques (70). Excision of the NAT1 cassette was
confirmed by Southern blotting using EcoRV digestion and a PCR-amplified
complete genomic copy of BNI1 as the probe (not shown).
For the second round of BNI1 deletion, oligonucleotides that were slightly
displaced from the genomic location of the original deletion to prevent recombination between the new flipper cassette and the regions flanking the excised
copy of BNI1 were designed. A PCR using primer set BNI518N generated the
KpnI-ApaI upstream fragment of BNI1, whereas primer set BNI518C generated
the SacII-SacI downstream fragment of BNI1. Ligation of these two fragments to
the ends of the NAT1 flipper cassette generated plasmid pBNIDEL518. Deletion
of the second copy of BNI1 was performed as described above.
Cloning and disruption of C. albicans MEA1. The Aspergillus nidulans MesA
amino acid sequence (60) was used as a query to search the predicted open
reading frames in the C. albicans genome (4) using BLASTP, leading to the
identification of ORF19.5919. Global alignment using Enboss Needle at EMBLEBI (http://ebi.ac.uk) showed 57.4% similarity and 20.7% identity between the
two sequences. In four previously identified conserved regions (60), homology
was as high as 65% similarity and 47% identity (see Fig. S1 in the supplemental
material for complete alignment analysis). The gene containing ORF19.5919 was
named MEsA1 or MEA1. A 2,482-bp DNA segment containing MEA1 was
synthesized by PCR using primer set MEA366 and genomic DNA as the template. This PCR product, which included 303 bp of upstream flanking sequence, 1,879 bp of coding sequence, and 300 bp of downstream flanking
sequence, was sequenced and cloned into the pBluescript SK(⫺) vector to
generate pBSMEA366. The MEA1 deletion strain MWY2 was generated in the
manner described above for the deletion of BNI1. Primer sets MEA500N and
MEA500C were utilized to generate MEA1 flanking regions for ligation to the
NAT1 flipper cassette and deletion of the first copy of MEA1, whereas primer
sets MEA700N and MEA700C were used for deletion of the second copy.
pBSMEA366 was used as template for the PCRs.
Insertion of the HWP1 reporter plasmid into bni1⌬/bni1⌬, bnr1⌬/bnr1⌬, and
pfy1⌬/pfy1⌬ deletion strains and Cdc42 point mutant strain AV03. The nourseothricin resistance marker was inserted into p1902GFP3 prior to transformation
into the bni1⌬/bni1⌬, bnr1⌬/bnr1⌬, and pfy1⌬/pfy1⌬ deletion strains as well as
the Cdc42 point mutant strain AV03. Plasmid JK795 (70), containing the complete NAT1 genomic region, was used as the template for primer set NAT1. The
resulting PCR-amplified fragment contained the complete NAT1 genomic region
flanked by SacI and SapI restriction sites at its 5⬘ and 3⬘ ends, respectively. This
fragment and p1902GFP3 were both digested with SacI and SapI and ligated
together to generate p1902GFP3NAT1, an HWP1 reporter plasmid that contains
URA3 and NAT1 markers on opposite sides of HWP1-driven GFP. This plasmid
was targeted to the enolase locus of each C. albicans strain of interest following
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ClaI linearization. Each strain was transformed via electroporation, selected on
YPD plates containing nourseothricin, and verified via Southern blotting using
BglII digestion and genomic enolase as a probe to recognize corresponding
sequences present in p1902GFP3NAT1 (not shown).
Examination of HWP1 gene expression in the CDC42 inducible deletion strain.
The p1902GFP3NAT1 plasmid was transformed by electroporation into SMC7A
and SMC8A (50) using the above methods. Transformants were selected on
YPD plates containing nourseothricin and confirmed by Southern blotting using
BglII digestion and genomic enolase as a probe (29) (not shown). Overnight
growth in yeast carbon base-bovine serum albumin media led to the excision of
the ectopic copy of CDC42 in SMC7A localized to the ACT1 locus in the manner
previously described for excision of the BNI1 flipper cassette to create a cdc42⌬/
cdc42⌬ strain. Analysis of the induced cdc42⌬/cdc42⌬ strain was carried out
under hypha-inducing conditions as described above.
Kinetic analysis of HWP1 gene expression. To examine HWP1 gene expression
and actin structures during the development of yeast buds and hyphal germ
tubes, strain HB-12 was grown under yeast- and hypha-inducing conditions as
described above. Cell samples were taken at 15-min intervals over a 120-min
period and examined for morphology, HWP1 gene expression, and actin by
differential interference contrast (DIC) and epifluorescence microscopy. To
quantitate HWP1 up-regulation rates, strain HB-12 with or without 1, 5, or 10
g/ml cytochalasin A or 10 g/ml jasplakinolide was analyzed every 10 min over
a 150-min period by fluorometry. Strains MWY1 and AV03 were analyzed in a
similar manner. Experiments were performed in triplicate.
Addition of exogenous cAMP to actin-deficient cells. Strain HB-12 was induced to form hyphae in the presence or absence of 5 g/ml or 10 g/ml
cytochalasin A and 10 mM dibutyryl-cAMP (Roche Diagnostics, Basel, Switzerland). Measurements were taken every 30 min over a 150-minute time period.
Strain MWY3 was analyzed in a similar manner. Experiments were performed in
triplicate and statistically analyzed as described below.
cAMP assay. Intracellular cAMP in Medium 199 was extracted as previously
described (16) and measured using the cAMP Biotrak enzyme immunoassay
system according to the manufacturer’s instructions (GE Healthcare, Piscataway,
NJ). Cells were prepared for hypha formation in the manner described above,
and samples were taken at 30-minute intervals over a 120-min time period.
Experiments were performed in triplicate and statistically analyzed as described
below.
Statistical analysis. Unless otherwise indicated, statistical analysis was performed using the one-way analysis of variance and Bonferroni’s multiple-comparison test performed with Prism 4.03 software (GraphPad, San Diego, CA).

which included latrunculin A (13), benomyl (22), propranolol,
(8), and ML-7 (45), that indicated loss of both HWP1 gene
expression and hypha formation (Fig. 1A).
By contrast, abrogation of hypha formation by the F-actin
stabilizer jasplakinolide (10, 68) and the reversible disruptor of
Golgi complex-mediated secretion brefeldin A (43) was not
accompanied by the abolition of HWP1 gene expression in
⬃90% of cells (Fig. 1C). Experiments using S. cerevisiae have
shown that jasplakinolide causes the formation of actin clumps
that are extremely stable, cannot be dispersed by the monomer
sequestering agent latrunculin A, and are therefore not dynamic (5). Nonetheless, the actin structures stabilized by jasplakinolide are structurally and functionally similar to normal
F-actin in that they continue to associate with proteins that
normally associate with F-actin and bind anti-actin antibodies
(5). As expected, stabilized actin clumps were observed in C.
albicans treated with jasplakinolide when detected with rhodamine-conjugated phalloidin (Fig. 2A).
Despite the blockage in hypha formation in jasplakinolideand brefeldin A-treated cells, hypha-inducing conditions were
required for HWP1 expression. Fluorescence reflecting HWP1
gene expression was not detected in yeast growth conditions
upon treatment with jasplakinolide or brefeldin A (Fig. 2B,
results with jasplakinolide). These results suggested that signal
transduction pathways that relay environmental conditions favoring HWP1 expression were not interrupted by treatment
with jasplakinolide or brefeldin A whereas the opposite was
true for cytochalasin A and the other drugs described above.
Detection of Hwp1 on drug-treated cells using indirect immunofluorescence. To determine if Hwp1 protein was detectable on cell surfaces, drug-treated cells of strain HB-12 were
examined for the presence of Hwp1 protein by the indirect
immunofluorescence assay using monospecific anti-Hwp1 antibody. Hwp1 was found exclusively on the surfaces of hyphae
in almost all untreated cells (Fig. 3, panel 2) and at discrete
regions on the surfaces of the vast majority of cells treated with
jasplakinolide or brefeldin A despite the lack of a discernible
hyphal structure (Fig. 3, panels 6, 8, and 10). In the case of
jasplakinolide-treated cells, multiple polarization sites containing Hwp1 could be detected, suggesting a loss in the ability to
organize and commit to a single site of hypha emergence.
Hwp1 was also clearly present in discrete surface aggregates on ⬃50% of cells that were blocked in hypha formation by cytochalasin A (Fig. 3, panel 4). Although GFP
reflecting HWP1 gene expression was not evident in the
merged epifluorescence and DIC image (Fig. 3, panel 3),
GFP was detectable at a low level in the dark-field fluorescent image of cytochalasin A-blocked cells compared to
yeast form cells (compare Fig. 1B, panel 6, and 1A, panel 2).
Similar results were also found for latrunculin A-treated
cells (not shown). In both cases, the majority of cells that
showed the presence of Hwp1 patches had a slightly oval or
pear-shaped appearance, a shape that is characteristic of
cells immediately prior to germ tube emergence. These results showed that the processes controlling polarization of
cell surface proteins in hypha-inducing conditions were retained during drug treatments that inhibited germ tube elongation and revealed the presence of a low level of HWP1 gene
expression under these conditions that was barely visible by epifluorescence microscopy to detect the GFP reporter.

RESULTS
Assessment of HWP1 gene expression in the presence of
drugs that interfere with Candida albicans hypha formation. A
chemical-genetic approach was initially utilized to assess the
relationship between HWP1 gene expression and hyphal morphogenesis. These experiments were performed using C. albicans strain HB-12 (29), in which the HWP1 coding region was
replaced by yEGFP3, leading to the presence of GFP throughout the cytoplasm of cells under germ tube-inducing conditions
but not yeast-inducing conditions (Fig. 1A). If the formation of
true hyphae were necessary for HWP1 expression, then cells in
which hypha formation was blocked by drug treatment would
also be unable to activate HWP1. Conversely, HWP1 expression during a drug-induced blockade of hypha formation could
bring to light information about processes that stimulate
HWP1 gene expression independently of physical hyphal structure.
As expected given the tight coupling between HWP1 gene
expression and hyphal growth, inhibition of hypha formation
using five of seven drugs tested was accompanied by the loss of
HWP1-mediated GFP fluorescence in the majority of cells examined (Fig. 1B). Control experiments verified that these results were not caused by a loss of cellular viability (see Materials and Methods). Results using the F-actin destabilizer
cytochalasin A (1) were typical of the results with other drugs,
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FIG. 1. HWP1 gene expression in the presence of drug treatments to disrupt hyphal morphology. (A) C. albicans strain HB-12, containing GFP
under the control of the HWP1 promoter, was incubated in conditions supporting yeast (1 and 2) or hyphal (3 to 6) growth. The addition of 2%
dimethyl sulfoxide (5 and 6) had no effect on hypha formation or GFP fluorescence. (B) Drug treatments that disrupted hyphal growth with loss
of HWP1 gene expression: cytochalasin A (1 to 6), latrunculin A (7 to 12), propranolol (13 to 18), benomyl (19 to 24), and ML-7 (25 to 30).
(C) Drug treatments that preserved HWP1 gene expression despite the loss of hypha formation included jasplakinolide (1 to 4) and brefeldin A
(5 to 10). Note that fluorescence reflecting HWP1 gene expression upon loss of hyphal morphology is intense with jasplakinolide at 10 g/ml and
is barely detectable with cytochalasin A at 10 g/ml in the dark-field image (B, 6). DIC microscopy (odd-numbered panels) and epifluorescence
microscopy (even-numbered panels) were used to detect morphology and HWP1 gene expression, respectively. Drugs were used at the indicated
concentrations.
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FIG. 2. (A) Correlation between HWP1 gene expression and the
presence of aggregated actin structures in strain HB-12 treated with 10
g/ml cytochalasin A or jasplakinolide under hypha-inducing conditions. F-actin was detected by staining with rhodamine-conjugated
phalloidin. F-actin was aggregated following treatment with 10 g/ml
jasplakinolide (2, arrow) but not with 10 g/ml cytochalasin A (4).
GFP fluorescence reflecting HWP1 gene expression was observed
in the presence of jasplakinolide (1) but not cytochalasin A (3).
(B) HWP1 gene expression was absent in cells grown under yeast
conditions in the presence or absence of 10 g/ml jasplakinolide.

Reduced HWP1 gene expression in mutants defective in Factin nucleation. The opposite effects of jasplakinolide treatment versus cytochalasin A or latrunculin A treatment on
HWP1 gene expression as assessed by measuring GFP production pointed to the possibility that actin dynamics plays a
pivotal role in HWP1 expression. The observation that cells
treated with jasplakinolide, which stabilizes actin and promotes
the formation of polymeric actin structures (5), retained HWP1
gene expression despite the lack of true hyphal development
suggested that F-actin in cells undergoing bud-hypha transitions may be important for the up-regulation of HWP1. To
obtain genetic evidence in support of this hypothesis, mutants
with defects in actin cable nucleation were analyzed for the
presence of reduced HWP1 gene expression.
Previous work with S. cerevisiae and C. albicans has demonstrated the importance of the formin gene BNI1 for efficient
actin cable formation and for C. albicans hyphal development
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(15, 41, 46). Therefore, a bni1⌬/bni1⌬ mutant strain (MWY1)
containing p1902GFP3NAT1 was created. Upon growth under
hypha-inducing conditions, the majority of MWY1 cells produced hyphae that were wider and less consistent in width than
wild-type hyphae (Fig. 4A). MWY1 also showed a reduction in
HWP1 gene expression, which was 63% of control levels as
detected by fluorometry (Fig. 4A and C). Identical results were
obtained using a bni1⌬/bni1⌬ strain produced in Yue Wang’s
laboratory (Institute of Molecular and Cell Biology, Singapore) (41).
Additional genetic data regarding the relationship between
hyphal morphogenesis and HWP1 gene expression were acquired using strain AV03, which contains a Cdc42 glutamic
acid-to-glycine alteration at residue 100 (78). The analogous
residue in S. cerevisiae Cdc42 is critical for activating Bni1 and
for formin-mediated actin assembly at sites of bud emergence (14,
51, 52, 78). AV03 cells transformed with p1902GFP3NAT1
showed alterations in hyphal structures that were similar to
those found for untransformed AV03 (i.e., hyphae were
shorter and wider than wild type [78]) (Fig. 4B). Quantitatively, HWP1 gene expression was present but was reduced to
47% of that seen in HB-12 under identical growth conditions
(Fig. 4B and C). This reduction is similar to the 63% level seen
in the bni1⌬/bni1⌬ background and is consistent with the predicted effect of a loss of interaction between Cdc42 and Bni1
(Fig. 4C). The reductions in fluorescence of the bni1⌬/bni1⌬
and AV03 strains transformed with p1902GFP3NAT1 compared to HB-12 were statistically significant.
The effect of the formins on HWP1 gene expression was
restricted to BNI1. The bnr1⌬/bnr1⌬ knockout did not deviate
from control cells in hypha formation or in the ability to activate HWP1 (Fig. 4C). Likewise, the actin monomer recruiter
profilin was not required. C. albicans profilin has been shown
to be functionally similar to S. cerevisiae profilin (59), and the
two proteins share extensive sequence homology (87% simi-

50,000

25,000

0
1

2

3
Strain

4

5

FIG. 4. HWP1 gene expression in mutants defective for actin nucleation. C. albicans strains CKFY254 (pfy1⌬/pfy1⌬), CKFY 354
(bnr1⌬/bnr1⌬), MWY1 (bni1⌬/bni1⌬), and AV03 (Cdc42 E100G) were
transformed with p1902GFP3NAT1 to monitor HWP1 gene expression
in comparison to strain HB-12 (A and B). Microscopic analysis of
hyphae by DIC (1, 3, and 5) and epifluorescence (2, 4, and 6) microscopy was performed to detect HWP1 gene expression in strains HB-12
and MWY1 (A) and AV03 (B). Note the decreased fluorescence of the
bni1⌬/bni1⌬ (A, 4 and 6) and Cdc42 E100G (B, 4 and 6) strains
compared to that of HB-12 (2), an effect that was not observed in
bnr1⌬/bnr1⌬ and pfy1⌬/pfy1⌬ cells (not shown). (C) Fluorometry to
quantitate HWP1 gene expression in the bni1⌬/bni1⌬ and Cdc42
E100G strains (strains 2 and 5; light bars) and in the HB-12, bnr1⌬/
bnr1⌬, and pfy1⌬/pfy1⌬ strains (strains 1, 3, and 4; dark bars). ⴱ, P ⬍
0.001 (bni1⌬/bni1⌬ strain versus HB-12 and Cdc42 E100G strain versus HB-12).

larity, 72% identity). The pfy1⌬/pfy1⌬ strain showed alterations
to hyphal structure similar to those observed in the bni1⌬/
bni1⌬ strain (not shown); however, HWP1 gene expression was
not reduced in pfy1⌬/pfy1⌬ cells (Fig. 4C).
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The genetic studies were consistent with the drug studies in
that reduced levels of HWP1 gene expression were found using
two mutants that are deficient in F-actin nucleation.
Kinetics of expression of the HWP1 gene relative to actin
polarization. To investigate the reasons for the differences in
GFP levels at 2.5 h between cells treated with jasplakinolide
and those treated with cytochalasin A or latrunculin A, the
kinetics of increases in GFP reporter expression over time
during germ tube inducing conditions were assessed.
(i) Microscopic analysis. The actin cytoskeleton and GFP
fluorescence reflecting HWP1 gene expression were analyzed
at 15-min intervals in cells grown under hypha-inducing or
yeast growth conditions (Fig. 5A). In hyphal cells at 30 min
postinduction, F-actin began to polarize to a site of germ tube
emergence but GFP fluorescence was not observed (Fig. 5A,
panels 7 to 9), confirming work from the Liu laboratory (24).
The polarization of actin to the site of the nascent germ tube
occurred just before GFP fluorescence became detectable, at
45 min postinduction (Fig. 5A, compare panels 8 and 9 to
panels 11 and 12). A rapid rate of increase in GFP fluorescence
that was quantified by fluorometry occurred after 60 min of
induction [see “Kinetics of expression of the HWP1 gene relative to actin polarization. (iii) Slow and fast kinetics of HWP1
gene expression during hypha induction”]. By contrast, GFP
fluorescence was not observed during budding and mitosis in
yeast cells.

(ii) Quantitation of F-actin in yeast and hyphal growth.
Previous work by Hazan et al. (24) suggested the presence of
permanently polarized actin at the point of germ tube emergence that was not dispersed during the G1 phase of the yeast
cell cycle, when cell cycle-regulated actin became depolarized.
This prompted questions regarding whether or not this apical
F-actin constituted an absolute increase in the amount of Factin during the emergence of germ tubes compared to that
during bud emergence. To address this question, we quantified
the total cellular F-actin from yeast and hyphal cells during the
first 60 min of induction according to previously described
procedures (28). Although a slight increase in F-actin levels in
hyphal cells relative to yeast cells was observed at 60 min, this
difference was not statistically significant (Fig. 5B), suggesting
that the observed aggregation of F-actin to both the nascent
germ tube and the nascent bud in their respective growth
conditions represents a redistribution of existing cellular Factin populations in response to polarization signals.
(iii) Slow and fast kinetics of HWP1 gene expression during
hypha induction. Previous work showed that the rate of HWP1
gene expression increased after 60 min of induction (29). To
explore the kinetics of HWP1 expression within the first 2.5 h
of induction, GFP fluorescence levels were monitored by fluorometry at 10-minute intervals. Two distinct rates of increasing fluorescence were observed; these reflected the presence of
a slow phase followed by a fast phase, with average rates of
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FIG. 6. Role of F-actin in the kinetics of HWP1 gene expression. (A) Cytochalasin A (cyto. A)-treated HB-12. (B) Jasplakinolide-treated (10
g/ml) HB-12 cells in the slow (1) or fast (2) phase of HWP1 gene activation. (C) Strains MWY1 (bni1⌬/bni1⌬) and AV03 (Cdc42 E100G). Each
graph in panels A to C is a representative example of experiments that were repeated three times.

135.7 and 362.7 fluorescence units/min, respectively (Fig. 6A).
The difference between the slow and fast rates of expression
was statistically significant (P ⬍ 0.001 using the paired Student
t test on data from three independent experiments). The transition period at 50 to 70 min postinduction roughly correlated
with both the appearance of intense actin polarization at the
emerging hypha (Fig. 5A) and the spike in cAMP that naturally
occurs following the shift to hypha-inducing conditions (7).
(iv) Effect of chemical or genetic interference with actin
dynamics on the kinetics of HWP1 gene expression. To further
examine the role of F-actin in HWP1 gene expression, kinetics
were examined with actin-influencing drugs as well as with
actin-compromised mutant strains. At concentrations of cytochalasin A that did not completely block germ tube formation (1 g/ml), the level of HWP1 expression in the fast phase
was reduced (Fig. 6A). At concentrations of 5 g/ml and 10
g/ml of cytochalasin A the fast phase was blocked (Fig. 6A).
By contrast, cells treated with 10 g/ml jasplakinolide showed
levels of HWP1 gene expression that were 70% of those seen in
the absence of drug with kinetics of expression that were identical to untreated cells (Fig. 6B).
The kinetics of HWP1 gene expression were also altered in
mutants with deficiencies in actin nucleation. The bni1⌬/bni1⌬
and Cdc42 E100G strains showed similar kinetics to HB-12
during the slow phase of expression (Fig. 6C). Although the
bni1⌬/bni1⌬ strain showed an increase in HWP1 gene expres-

sion during the fast phase, this increase was reduced relative to
HB-12. The bni1⌬/bni1⌬ strain appeared to enter the fast
phase of HWP1 gene expression, but the fast phase was not
maintained. The Cdc42 E100G strain showed slight increases
in HWP1 expression levels that were markedly reduced in
comparison to those shown by HB-12.
The results of the kinetic analysis suggested that activation
of HWP1 gene expression occurs by a two-step process consisting of a slow actin-independent phase followed by a fast
F-actin-dependent phase. While GFP reporter levels reflecting
HWP1 activation are measurable by fluorometry during the
slow phase of expression, it is only after 50 to 70 min of
induction, when actin is polarized to the site of apical growth
in the majority of cells (Fig. 5A), that rapid up-regulation of
HWP1 occurs and GFP is readily visualized by epifluorescence
microscopy of single cells. Only the fast phase is disrupted
by the use of chemical or genetic disruptors of F-actin, implicating F-actin as a central player in the fast phase of HWP1
expression. Although GFP levels are slightly reduced at each
time point in jasplakinolide-treated cells in the fast phase,
the kinetics of the fast phase of activation are neither diminished nor enhanced by jasplakinolide, which stabilizes and extends existing filaments and causes filament nucleation de novo
(68).
HWP1 expression and localization in the absence of polarization. (i) CDC42. CDC42 is an essential gene in S. cerevisiae
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FIG. 7. Presence of HWP1 gene expression in cells made defective
for cell surface polarization using chemical and genetic methods. Interference with cell surface polarization was accomplished using
SMC7A grown under conditions leading to the loss of CDC42 (A) or
using strains MWY1 (bni1⌬/bni1⌬) and MWY2 (mea1⌬/mea1⌬) that
had been treated with cytochalasin A (B). Strain HB-12 served as a
wild-type control. Strain HB-12 showed a punctate distribution of
Hwp1 (B, 2, black arrow), in contrast to cells in which polarization was
inhibited (B, 4 and 6, white arrows).

and C. albicans (26, 51). However, the loss of CDC42 can be
studied by using strain SMC7A, in which CDC42 can be inducibly deleted following growth in yeast carbon base-bovine
serum albumin medium and subsequent excision of an ectopic
copy of CDC42 from the genome (50). Loss of CDC42 gave
rise in most cases to large, round cells that had lost the ability
to exhibit polarized growth and were terminal (Fig. 7A). Measurable GFP fluorescence was found under hypha-inducing
conditions in strain SMC7A, which had been transformed with
p1902GFP3NAT1, despite the inability of the cells to form true
hyphae. This result added additional genetic evidence for the
independence of the regulatory pathways governing the formation of true hyphal structures and HWP1 expression. Indirect immunofluorescence assays showed that Hwp1 was
present on cell surfaces but was not confined to specific areas;
rather, Hwp1 was extended across the entire cell surface (Fig.
7A). Polarization of the cell surface was not required for high
levels of HWP1 expression, which could be determined by
measuring GFP fluorescence.
(ii) Drug treatments of mutants with defects in polarization.
The role of Bni1 in cell polarization has been previously described (14, 36). The C. albicans MEA1 gene is similar to MesA
of Aspergillus nidulans, which encodes a protein responsible for
the localized assembly of actin cables at polarization sites by
recruitment of the formin SepA (60) (see Fig. S1 in the supplemental material). As expected, HWP1 gene expression was
not sufficient to elicit detectable fluorescence from the GFP
reporter for either mutant or for HB-12 in the presence of

cytochalasin A (Fig. 7B, panels 1, 3, and 5). The low level of
Hwp1 characteristic of the early stage of HWP1 gene expression was present in both mutants as well as in HB-12; however,
Hwp1 was not polarized in the mutant strains but was more
evenly distributed over the cell surface. Thus, polarization
events were not required for the initial low-level stage of expression of HWP1.
Expression of HWP1 by stabilized actin involves the cAMP
pathway. (i) Studies using cAMP hypo- and hypermorphic
strains of C. albicans. Recent work using S. cerevisiae endocytosis mutants that display reduced actin dynamics and the
presence of F-actin aggregates has shown that an up-regulation
of the cAMP signaling pathway is associated with F-actin aggregation and that the adenylyl cyclase-associated protein,
Srv2p (also called Cap1), is required for increases in cAMP
(21). To investigate whether HWP1 gene expression in the
presence of stabilized actin structures was also related to activation of the cAMP pathway, GFP fluorescence and actin
structures were monitored in a strain that constitutively overexpresses PDE2 (EPDE2-3) (6), causing enhanced degradation of cAMP. The HWP1GFP reporter gene was introduced
into strain EPDE2-3 using plasmid p1902GFPNAT1. Overexpression of PDE2 eliminated observable GFP fluorescence
among jasplakinolide-treated cells despite the presence of
stabilized actin structures (Fig. 8A, panels 1 and 2). HWP1
gene expression in the presence of jasplakinolide was also
not observed in the srv2⌬/srv2⌬ mutant strain, which is deficient in the activation of the cAMP pathway (7) (Fig. 8A,
panels 3 and 4).
The initial stage of HWP1 gene expression was not dependent on the cAMP signaling pathway. Surface Hwp1 as
detected by indirect immunofluorescence was present in a
distinct patch on surfaces of srv2⌬/srv2⌬ and EPDE2-3
strains (Fig. 8B, panels 2 and 4), arguing against a role for
the cAMP signaling pathway in the initial stage of HWP1
gene expression. However, the data strongly suggest that
activation of the cAMP signaling pathway is related to the
expression of HWP1 to the high levels required for detection
via GFP reporter fluorescence in the presence of stabilized
actin.
(ii) The effect of chemical or genetic interference with Factin on cAMP levels. If the loss of HWP1 gene expression in
cytochalasin A- and latrunculin A-treated cells is related to
reduced cAMP levels, then cells treated with these drugs
should have reduced levels of cAMP compared to untreated
cells. Furthermore, mutants with defects in actin nucleation
should also exhibit reduced levels of cAMP. The addition of 10
g/ml cytochalasin A to HB-12 cells reduced intracellular levels of cAMP to one-half the level seen in untreated cells following 60 min of induction, a time that coincides with the
slow/fast phase transition (Fig. 8C). A gradual decline in
cAMP levels followed the 60-minute time point. By contrast,
latrunculin A (50 g/ml) did not alter the peak of cAMP at 60
min; however, a reduction in intracellular cAMP to 66% of
untreated-cell levels by 120 min postinduction was observed.
The difference in magnitude between the cytochalasin A and
latrunculin A results up to 90 min postinduction could be
related to the slow monomer-sequestering mechanism by
which the latter acts on actin filaments (13). Also, the disruption to the actin cytoskeleton by latrunculin A-based actin
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FIG. 8. Role of cAMP in actin-mediated HWP1 gene expression. (A) HWP1 gene expression and F-actin staining in EPDE2-3 (PDE2
overexpression) (1 and 2) and MWY3 (srv2⌬/srv2⌬) (3 and 4) strains exposed to 10 g/ml jasplakinolide under hypha-inducing conditions.
(B) Localization of Hwp1 to a distinct region on cell surfaces of the srv2⌬/srv2⌬ and PDE2 overexpression strains (2 and 4, arrows). HWP1 gene
expression was insufficient to be detectable by measuring the fluorescence of the GFP reporter in both genetic backgrounds (1 and 3).
(C) Intracellular cAMP levels of cells treated with actin-influencing agents. ⴱ, P ⬍ 0.001 (no drug versus 10 g/ml cytochalasin A [cyto. A] at 60
min and no drug versus 10 g/ml cytochalasin A, latrunculin A, and jasplakinolide at 120 min). (D) Intracellular cAMP levels of actin-compromised
mutant cells. ⴱ, P ⬍ 0.001 (no drug versus both mutant strains at 60 min). (E) HWP1 gene expression in the presence of 5 or 10 g/ml cytochalasin
and the presence or absence of 10 mM dibutyryl (db)-cAMP. ⴱ, P ⬍ 0.001 (5 g/ml and 10 g/ml cytochalasin A plus db-cAMP versus no
dibutyryl-cAMP, at 150 min). (F) HWP1 gene expression of strain MWY3 (srv2⌬/srv2⌬) in the presence (inverted triangles) or absence (triangles)
of 10 mM dibutyryl-cAMP. ⴱ, P ⬍ 0.01 (with dibutyryl-cAMP versus no dibutyryl-cAMP at 150 min).

monomer sequestration may result in an overall decline of
cAMP production in latrunculin A-treated cells despite the
initial increase. This decline, in turn, would be reflected in a
decline in HWP1 gene expression (Fig. 1B, panels 7 to 12).
By contrast, jasplakinolide treatment (10 g/ml) led to
cAMP levels that were 75% of those in untreated cells at 60

min and surpassed levels found in untreated cells at 120 min
postinduction, demonstrating a sustained gradual increase
over time in cAMP levels in response to jasplakinolidemediated stabilized actin. The sustained increase in cAMP
levels seen in jasplakinolide-treated cells with stabilized actin was similar to the sustained increase previously observed
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in a pde2⌬/pde2⌬ strain in which cAMP degradation is inhibited (6).
Examination of intracellular cAMP levels in the bni1⌬/bni1⌬
and Cdc42 E100G strains revealed a loss in the peak of cAMP
production that occurred in strain HB-12 at 60 min postinduction (Fig. 8D). At the 60-min time point, the bni1⌬/bni1⌬ and
Cdc42 E100G strains showed cAMP levels at 46% and 26%,
respectively, of the peak cAMP levels observed from HB-12.
By 120 min postinduction, however, the cAMP levels in the
actin-compromised mutant strains were close to HB-12 levels.
(iii) Partial recovery of HWP1 gene expression by exogenous
cAMP. The addition of 10 mM dibutyryl-cAMP to HB-12 cells
treated with 5 g/ml and 10 g/ml cytochalasin A resulted in
1.5- and 1.75-fold increases in HWP1-derived GFP fluorescence following 150 min of induction, to levels that were 38%
and 18% of HB-12 levels, respectively (Fig. 8E). The results
were statistically significant and suggested that cAMP was able
to partially rescue the effects of cytochalasin A concentrations
that normally curtail hypha formation and HWP1 gene expression. Higher concentrations of dibutyryl-cAMP did not further
increase GFP reporter fluorescence. Treatment of the srv2⌬/
srv2⌬ strain with 10 mM dibutyryl-cAMP yielded a twofold
increase in HWP1 gene expression compared to that in untreated cells, although after partial rescue levels were only 13%
of those seen in untreated HB-12 cells (Fig. 8F). These partial
recoveries of HWP1 gene expression by dibutyryl-cAMP support the relationship between actin cytoskeletal aggregates and
activation of the cAMP pathway.
Together, the data show that conditions that interfere with
F-actin formation also affect the kinetics of cAMP levels in
wild-type cells, which peak at 60 min when polarized F-actin
becomes present in cells prior to germ tube emergence, beginning at 30 min (Fig. 5A). The results suggest a correlation
between the presence of stabilized actin and increasing cAMP
levels during the slow phase of HWP1 gene expression, which
precedes the rapid phase of induction. The results also underscore the importance of rapid cAMP production at the budhypha transition prior to the fast phase of HWP1 gene expression and the strong contribution of stabilized F-actin to the
development and maintenance of this cAMP activation. Factin aggregation alone was not sufficient to override mutations in the cAMP pathway, and the disruption of actin aggregation resulted in marked declines in intracellular cAMP levels
among cytochalasin A-treated cells as well as actin-compromised mutant strains.
DISCUSSION
A major outcome from the work described in this study is
the discovery that actin dynamics play a major role in activating
HWP1 gene expression. The up-regulation of HWP1 gene expression in the presence of hyphal blockade by jasplakinolide
but not cytochalasin A or latrunculin A strongly suggested that
actin structures are involved in HWP1 gene expression. The
results of our studies suggested the existence of major parallels
to the role of actin structures in apoptotic pathways in S.
cerevisiae. Reductions in actin dynamics in S. cerevisiae caused
by jasplakinolide or by mutations in genes that function in the
endocytic pathway lead to the presence of large clumps of
F-actin aggregates within cells that activate the cAMP signal-
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ing pathway, increase reactive oxygen species (ROS) production, and ultimately lead to apoptosis (5). Increases in oxygen
radical generation during germ tube induction have also been
observed in C. albicans (67), suggesting the possibility that
changes in actin dynamics during morphogenesis may be related to the generation of oxygen radicals. Unlike the apoptotic
response to stabilized actin in S. cerevisiae, however, the effect
of jasplakinolide on C. albicans with respect to activating
HWP1 depended on the presence of hypha-inducing conditions. Specifically, HWP1 gene expression did not occur in cells
treated with jasplakinolide under yeast-inducing conditions despite the presence of stabilized F-actin structures (Fig. 2B).
These findings strongly suggest that alterations to actin dynamics at the bud-hypha transition result in the remodeling of
F-actin structures during morphogenesis that occurs simultaneously with the presence of environmental signals to activate
gene expression at the HWP1 locus.
It is important to acknowledge the potential difficulties with
interpreting results from drug studies. Cytochalasin A is chemically similar to the thiol-alkylating agent N-ethylmaleimide
(NEM) and has secondary effects on cell metabolism and thiol
alkylation in mammalian cells that are unrelated to effects on
actin (18, 32, 35). In this study, unlike studies with mammalian
cells in which NEM did not interfere with actin filaments (18),
NEM did in fact interfere with actin polymerization in C.
albicans (not shown). The differential effect of NEM on actin
from C. albicans compared to mammalian cells points to an
intrinsic difference in sensitivity to oxidation between the two
actins in their respective environments that may reflect the
observation by us and others (32) that yeast and fungi are
sensitive to cytochalasin A but not to cytochalasin B. Support
for a role for oxidation in actin depolymerization is provided by
recent studies showing that oxidation of mammalian actin by
peroxide can cause a complete loss of polymerization potential, an effect involving cysteine 374 (40), which is conserved in
C. albicans actin. Thus, the influence of thiol alkylation on
hyphal development and HWP1 expression does not preclude
the correlation between F-actin and HWP1 expression.
Consistent with the importance of reduced sulfhydryl groups
in F-actin function, the simultaneous addition of dithiothreitol
(DTT) (1 mM) and cytochalasin A (0.02 mM) prevented the
complete depolymerization of actin and partially rescued
HWP1 gene expression (not shown). GFP levels attained 70%
of the level seen in untreated cells in the presence of DTT and
cytochalasin A, which was equivalent to GFP levels in the
presence of jasplakinolide. Importantly, DTT alone also
blocked germ tube formation, but actin was not depolarized or
depolymerized and HWP1 gene expression was again retained
at the level of 70% of that seen in untreated cells. The effect of
DTT alone on blocking germ tube formation could be explained by the selective retention of secretory proteins in the
endoplasmic reticulum (25). The effect of DTT was similar to
that of brefeldin A in preventing germ tube formation but not
actin polymerization or HWP1 gene expression (see below).
Thus, the results of germ tube blockage using NEM, DTT, and
DTT plus cytochalasin A were consistent with the correlation
between the absence or presence of F-actin and the loss or
presence, respectively, of HWP1 gene expression as assessed
by measuring GFP fluorescence using epifluorescence microscopy.

VOL. 6, 2007

ACTIN DYNAMICS AND HWP1 GENE EXPRESSION

The importance of F-actin in HWP1 gene expression was not
solely based on treatments with cytochalasin A. Latrunculin A,
an actin filament destabilizer like cytochalasin A, produced
identical losses in hypha formation and HWP1 gene expression
as cytochalasin A but required higher drug concentrations
(0.12 mM versus 0.02 mM) to attain them, a fact reflective of
the monomer-sequestering mechanism by which latrunculin A
functions (13). Jasplakinolide, an actin filament stabilizer, produced the opposite effect of the actin-destabilizing drugs. The
correlation between F-actin and HWP1 gene expression was
also supported by genetic studies and kinetic analyses discussed in the previous section as well as below.
The effect of brefeldin A on hypha formation and HWP1
gene expression is also consistent with a central role for stabilized F-actin in the regulation of both processes. Brefeldin A
acts as a specific disruptor of Golgi complex-mediated secretory processes (9, 43), while leaving other cellular processes,
such as those involving the actin cytoskeleton, unaltered (30).
Whereas recent work has revealed that Bni1-mediated actin
cables are necessary for positioning the Golgi complex to a
putative site of germ tube emergence and for coordinating the
transport and deposition of membrane and cell wall material to
a growing hypha (65), actin dynamics would not be expected to
change in response to the bud-hypha transition in cells with a
chemically dispersed Golgi complex. However, we found that
the loss of Golgi complex-mediated secretion prevented hypha
development in cells treated with brefeldin A, implicating the
Golgi complex as a central player in bud-hypha transitions.
These results vary from the recently published findings of Rida
et al. (65), since brefeldin A was added to cells simultaneously
with the shift to hypha-inducing conditions in our experiments
rather than allowing hyphal structures to develop prior to drug
addition as in the study by Rida et al. (65). Addition of brefeldin A during the bud-hypha transition would not be expected
to interfere with actin dynamics and subsequent expression of
HWP1. However, the inability of these cells to form a coherent
Golgi complex at the site of hypha formation (65) prevented
hypha development, resulting in cells with a yeast-like morphology despite the expression of hypha-specific genes. The
results using brefeldin A-treated cells further support the importance of hypha-inducing environmental conditions in
HWP1 expression as well as the idea that the yeast morphology
is not incompatible with the type of actin dynamics that can
promote cAMP pathway up-regulation, leading to the expression of genes that are usually hypha specific.
The effects of benomyl, propranolol, and ML-7 on hyphal
development and HWP1 gene expression may also be examined within the context of F-actin. It has been previously shown
that the actin cytoskeleton is disrupted along with microtubules
upon benomyl treatment (1), which accounts for the cytochalasin A- and latrunculin A-like phenotype observed in our
benomyl experiment. Actin bundle disruption and filament
depolymerization have also been observed in connection
with the use of propranolol (23, 55) and ML-7 (36, 53),
suggesting that the stabilization of F-actin may be a common
explanatory thread linking the results of all seven of the
drugs analyzed in this study.
The contribution of F-actin structures to HWP1 gene expression is supported by genetic data. First, in terms of the ability
to activate HWP1, strains lacking the formin gene BNI1 dif-

fered markedly from strains lacking the profilin gene PFY1
despite strong similarities in their morphological defects to
hyphal cells. Specifically, HWP1 gene expression was decreased
in bni1⌬/bni1⌬ cells and unaffected in pfy1⌬/pfy1⌬ cells. Recent work has shown that Bni1 is localized primarily to the
developing hypha tip and that its presence is necessary for the
development of a wild-type hyphal structure though not for
overall apical growth (41). The reduction in HWP1 gene expression in the bni1⌬/bni1⌬ mutant could be related to a compromise to the formin-mediated actin cytoskeletal network
that is essential for wild-type hyphal development. While not
preventing hyphal morphogenesis per se, the loss of BNI1 may
prevent the synthesis of appropriate F-actin structures necessary at the bud-hypha transition for the formation of a cell
exhibiting wild-type levels of hypha-specific gene expression
(41). Therefore, the finding that deletion of BNI1 compromises
HWP1 expression both in the strain generated in this work and
the strain generated by Li et al. (41) provides direct genetic
evidence supporting the drug studies that specific F-actin structures contribute to HWP1 gene expression. By contrast, loss of
Pfy1 would reduce the efficiency of actin rearrangements during hyphal morphogenesis but not preclude them, allowing
HWP1 gene expression to persist in a pfy1⌬/pfy1⌬ null mutant.
The importance of stabilized F-actin to the HWP1-regulatory process was also supported by the reduction in HWP1
gene expression in a strain carrying a specific glutamic acid-toglycine alteration (Cdc42 E100G) encoded by CDC42 (78) that
leads to deficient interactions with Bni1 (51). Work with S.
cerevisiae has implicated Cdc42 as a direct mediator of actin
cytoskeletal dynamics during polarized morphogenesis through
its physical interactions with Bni1 (14). More-recent work suggests that this Cdc42-Bni1 interaction exists in C. albicans as
well and that compromises to this interaction have deleterious
effects on hypha formation (78). The level of HWP1 gene
expression in the Cdc42 E100G strain compared to that in
HB-12 (47%) mirrored the level observed in the bni1⌬/bni1⌬
strain (63%), which is consistent with the idea that forminbased actin filament rearrangements play a critical role in
HWP1 expression. Assessing further compromises to HWP1
expression by the simultaneous deletion of both C. albicans
formins is not possible because C. albicans bni1⌬/bni1⌬ bnr1⌬/
bnr1⌬ cells are inviable (41).
Although the exact nature of the native actin structures that
may support the expression of HWP1 during the bud-hypha
transition is not known, it is possible that F-actin aggregates
that are similar to those observed in a fraction of the cells in
stationary-phase cultures of S. cerevisiae may be present (20)
except that the aggregated F-actin in germ tubes is polarized at
the apex of the emerging germ tube. The possibility that overall
increases in F-actin levels are involved is considered to be
unlikely based on the low level of G-actin reserves in S. cerevisiae, which have been measured to be 1% of total actin (5).
Indeed, our quantitative analysis did not reveal a difference
between the level of total F-actin in cells forming nascent germ
tubes or nascent buds. An alternative possibility is that F-actin
from cortical patches coalesces and is incorporated into hyphaspecific F-actin structures in the emerging germ tube in a
manner analogous to the convergent-evolution model of
filopodial initiation (76). F-actin aggregates could also arise
following the dissolution of preexisting F-actin and nucleation
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of new structures that would support HWP1 gene expression.
The presence of polarized F-actin that is specific to hyphal
growth and is not influenced by cell cycle cues has been previously described (24). Concentrated F-actin (2) at hyphal tips
may be functionally similar to jasplakinolide-induced structures, a fact that may account for the effect of jasplakinolide on
HWP1 gene expression despite the lack of germ tube development that occurs upon jasplakinolide treatment.
A possible mechanism by which F-actin contributes to
HWP1 gene expression is through involvement of the cAMP
signaling pathway. The importance of activation of the cAMP
signaling pathway to HWP1 up-regulation was demonstrated in
our previous work using hypo- and hypermorphic cAMP mutants (6). Here, multiple approaches pointed to a connection
between F-actin and cAMP. First, the cAMP increase that
normally occurs and peaks within 60 min of hypha induction
was largely abrogated in the presence of cytochalasin A treatment as well as in mutants that are deficient in the nucleation
of F-actin. Although latrunculin A did not inhibit the cAMP
peak, cAMP levels during the fast phase of HWP1 gene expression were significantly reduced compared to those in untreated cells after 120 min. Second, measurements of intracellular cAMP in cells treated with 10 g/ml jasplakinolide
revealed a gradual but sustained increase in cAMP levels during hypha induction that did not decline over time but rather
continued to increase during the fast phase of HWP1 gene
expression. Third, the absence of Srv2 as well as the overexpression of PDE2, which encodes the high-affinity phosphodiesterase that degrades cAMP, led to the loss of HWP1 gene
expression in the presence of jasplakinolide-stabilized actin
structures. The absence of HWP1 gene expression despite the
presence of jasplakinolide-stabilized actin in hypha-inducing
conditions was consistent with the idea that elevated levels of
cAMP are responsible for HWP1 gene expression in association with F-actin. A similar experiment using overexpression of
the PDE2 gene was used in S. cerevisiae to demonstrate the
importance of cAMP signaling in the presence of stabilized
actin (20). Fourth, the addition of dibutyryl-cAMP partially
reversed the genetic and chemical-genetic interference with
F-actin polymerization.
The data from this study suggest that the mechanisms leading to HWP1 gene expression share similarities to the F-actinrelated increases in release of ROS from mitochondria that
precede apoptosis in S. cerevisiae. Mutations in the sla1 or end3
genes (21) interfere with the actin dynamics that accompany
endocytosis, stabilize F-actin, and hyperactivate the Ras/cAMP
pathway. Adenylyl cyclase and the cyclase-associated protein
Srv2 were observed to colocalize with stabilized actin. The
colocalization of stabilized actin and cAMP pathway components was accompanied by concomitant increases in cytoplasmic cAMP levels, oxygen radicals, and apoptosis, leading to the
conclusion that stabilized actin structures and hyperactivation
of the cAMP signaling pathway were interrelated. Apoptosis
and the presence of ROS have also been described for C.
albicans (61, 62), and connections between these processes and
germ tube formation are indicated by an increase in ROS at
the time of germ tube formation (67). The incomplete rescue
of C. albicans HWP1 gene expression by dibutyryl-cAMP in the
presence of genetic and chemical-genetic compromises to Factin parallels the lower levels of ROS generated upon addi-
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tion of exogenous cAMP to a pde2 mutant compared to ROS
levels generated by the endocytosis mutants of S. cerevisiae and
is suggestive of a similar relationship between the cAMP signaling pathway and F-actin in the two organisms. The possibility that hypha-inducing conditions impact mitochondrial
function is suggested by the interference of these conditions
with electron transport, a shift to fermentative metabolism,
and impairment in oxygen uptake (37). Finally, a recent result
from the literature that is also consistent with the correlation
between the presence of stabilized actin and activation of the
cAMP pathway in C. albicans was the finding that a C. albicans
sla2⌬/sla2⌬ mutant did not show alterations in cAMP-regulated gene expression despite the inability to form true hyphae
(58). C. albicans sla2⌬/sla2⌬ null mutants would be predicted
to have a block in endocytosis-associated actin dynamics and
stabilization similar to that of S. cerevisiae sla1⌬/sla1⌬ mutants
given the related roles of Sla1p and Sla2p in S. cerevisiae
endocytosis (52).
Despite the intriguing similarities mentioned in the previous
paragraph, there are unexplained differences between pathways leading to HWP1 gene expression and pathways leading
to apoptosis in both S. cerevisiae and C. albicans. Little is
known about the exact signaling mechanisms that limit HWP1
gene expression to hypha-inducing growth conditions, the potential colocalization of the C. albicans cAMP pathway components Srv2 and Cyr1 (adenylyl cyclase) with aggregated Factin, the functional roles of the C. albicans protein kinase A
(PKA) isoforms Tpk1 and Tpk2 at the bud-hypha transition in
comparison with the established roles of S. cerevisiae PKA
isoforms in apoptosis, and the differences in F-actin organization and interactions with cAMP between S. cerevisiae and C.
albicans that permit balanced hyphal growth and reversion to
yeast growth conditions in the latter case. Future research to
investigate these questions is likely to have a high impact on
the understanding of the mechanisms of candidiasis that relate
to interconversion between C. albicans growth morphologies.
Srv2 of C. albicans could be important for the coupling of
F-actin dynamics and cAMP pathway activation that leads to
HWP1 gene expression (7). In this work, we found that HWP1
was not expressed in the srv2⌬/srv2⌬ mutant even though stabilized actin structures could be induced by jasplakinolide,
suggesting that cAMP activation is necessary for HWP1 gene
expression and that the Srv2 protein is essential to this process.
In S. cerevisiae, it has been shown that Srv2 localizes to actin
patches at the site of endocytosis as well as to stabilized actin
structures that are generated in the mutants with defects in
endocytosis (21). It is possible that Srv2 serves as a sensor of
changes in actin dynamics that are translated into activation of
the cAMP pathway. Srv2 has been shown to consist of an
N-terminal region that primarily interacts with adenylyl cyclase, a central polyproline region that indirectly interacts with
F-actin via Abp1, and a C-terminal region with GDP-actin
monomer binding ability that facilitates localized actin turnover (42, 48). It is logical that Srv2 could serve as a downstream
signaling target for the rapid remodeling and polarization of
actin filaments that takes place in response to external signals.
Indeed, in the recent work previously mentioned that implicated S. cerevisiae actin stabilization with Ras/cAMP pathway
activation (21), it was also found that Srv2 played a key role as
a signaling conduit between actin filaments and the activation
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FIG. 9. Model for biphasic expression and up-regulation of HWP1 at the bud-hypha transition. (A) In the initial-expression phase, environmental signals activate undetermined signal transduction pathways, allowing for small-scale HWP1 gene expression as shown by the gray arrow.
Stabilized actin is not required for this gene expression. This initial HWP1 expression occurs simultaneously with polarization events resulting from
Cdc42 interactions with Bni1 in conjunction with other proteins, such as Mea1p, that lead to localized Hwp1 deposition on the cell wall surface.
While Cdc42 interactions with Bni1 may be promoting formin-based actin filamentation at this stage, HWP1 gene expression is not contingent on
the presence of these filaments. (B) Actin structures play a direct role in the amplification and sustaining phase. Bni1-nucleated F-actin aggregates
act as a platform for Srv2/Cap1 aggregation, which in turn serves as a regulatory conduit in the activation of the cAMP pathway and its effectors,
leading to the production of ROS. These cAMP/PKA effectors are joined by a number of independently up-regulated activators and downregulated repressors (11, 27, 54, 56, 64, 69, 79) that may act upon HWP1 in a direct or indirect manner. Work by other groups has suggested that
these factors may be regulated in part by Cdc42 (46, 50, 77, 78). These changes in regulatory factor expression allow for increased HWP1 gene
expression levels in response to various environmental signals, as represented by the large black arrow.

of cAMP-related downstream effectors. This intriguing finding
implies that cAMP pathway activation and up-regulation at the
bud-hypha transition may promote the formation of stabilized
actin structures via Srv2 interaction, thereby facilitating the
presence of sustained actin polarization at the nascent germ
tube and increasing HWP1 expression. Given what has been
discovered in recent years regarding the complexities of C.
albicans regulation of hyphal morphogenesis, however, it is
also likely that additional proteins that contribute to this actinbased regulatory process will be discovered.
One interesting idea raised by the production of oxygen
radicals as a by-product of the bud-hypha transition is that
these oxygen radicals may play a role in regulating factors that
control HWP1 gene expression. Current opinion regarding the
regulation of HWP1 is that initial activation of the Ras/cAMP
pathway targets transcription factors such as Efg1 for HWP1
activation. Based on what is known about the role of oxygen
radicals and the Hog1 pathway in terms of hypha formation, it
is possible that stress response genes activated in response to
oxygen radical generation may contribute to HWP1 up-regulation (49, 67). It is also possible that the Hog1 oxidative stress
response pathway may control not only the level of oxygen
radicals in the transitioning cell but also the overall bud-hypha
structural transition since cells with a constitutively active
Hog1 pathway are unable to form hyphae (49). These results,
taken together, suggest that the ability of C. albicans to pro-

duce a spike in oxygen radicals at the bud-hypha transition (67)
may represent another mechanism by which bud-hypha regulatory pathways are controlled.
Our examination of Hwp1 localization using indirect immunofluorescence revealed the presence of Hwp1 at patches on
the cell surface that were predicted to represent sites of emerging hyphae. The presence of Hwp1 at localized surface patches
was indicative of a low level of HWP1 gene expression that was
difficult to detect in individual cells by visualizing fluorescence
from the GFP reporter and did not require the presence of
stabilized actin structures. Interestingly, this initial low level of
expression did not appear to require the polarization events
that accompany germ tube emergence since cells induced to
excise the essential CDC42 gene were found to have surface
Hwp1 localization that was not restricted to aggregated
patches. Likewise, deletion of other factors that are believed to
play a role in the polarization of C. albicans at the bud-hypha
transition, such as BNI1 or MEA1, affected Hwp1 localization
but did not prevent low-level HWP1 gene expression. A role
for the cAMP signaling pathway in the initial stage of HWP1
gene expression was not found. The srv2⌬/srv2⌬ mutant exhibited localized surface Hwp1 that was indistinguishable from
that of HB-12. The central role played by Cdc42 in the initial
stages of the bud-hypha transition argues that additional
CDC42-mediated pathways beyond BNI1 play key roles in the
activation of HWP1 gene expression. These additional path-
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ways may include as yet unidentified linkages between Cdc42
and critical bud-hypha transition downstream effectors, including modifiers of actin architecture such as the Arp2/3 complex
activator Wal1, the transcriptional activators Cph2 and Tec1,
and the transcriptional repressors Tup1 and Nrg1 (44, 46).
Additional study of Cdc42-mediated regulation of the budhypha transition is necessary to develop a complete picture of
the complex interactions that take place between these pathways in the regulation of hypha-specific transcripts like HWP1.
It is important to note that this study has focused exclusively
on the HWP1 gene as a model for hypha-specific gene regulation in C. albicans. Nevertheless, these findings may reflect a
more general model of biphasic hypha-specific gene expression. Indeed, the hypha-specific adhesin Als3 is known to share
a similar promoter structure and set of candidate regulatory
factors with Hwp1 (3), suggesting the possibility for actininfluenced regulation at this locus as well.
Another major finding from this work is the recognition of a
new role for F-actin in C. albicans, which is already known to
be essential for hyphal growth (1) and is enriched in the region
of the Spitzenkörper (12), a structure whose position in the
growing hypha determines the directionality of growth. Our
studies suggest that F-actin structures form a close interrelationship with the cAMP signaling pathway and serve to upregulate the synthesis of cAMP, thereby activating the expression of HWP1 and potentially other hypha-specific genes. Thus,
our chemical-genetic and genetic approaches provide a mechanistic explanation for the close correlation between cytoskeletal dynamics during morphogenesis and hypha-specific gene
expression. This finding is consistent with work in mammalian
cells that also suggests that actin rearrangements can directly
influence genetic regulation programs (34).
The indirect immunofluorescence and kinetic experiments
described in this study delineate the steps in a pathway of
developmental regulation of hypha formation in C. albicans
(Fig. 9). The initial stage corresponds to the slow phase from
the kinetics studies and is characterized by polarization events
at the site of emergence of the nascent hypha that are accompanied by deposition of Hwp1 and possibly other developmentally regulated proteins. The treatment of cells with drugs that
destabilized or did not permit formation of F-actin blocks the
onset of the second phase. Little is known about the mechanisms mediating the initial stage of germ tube polarization
events; however, the formation of F-actin and the activation of
the cAMP pathway are not required. The second stage in the
pathway corresponds to the fast phase from the kinetics studies. This phase is dependent on F-actin aggregation that normally coincides with germ tube elongation but can be artificially replaced by drug treatment that stabilizes F-actin prior to
the turnover that is required for restructuring the cytoskeleton
to facilitate hyphal growth. F-actin during germ tube formation
is interrelated with the activation of the cAMP signaling pathway and a high level of amplification of HWP1 gene expression.
More research is required to elucidate the factors involved in
initiation of this developmental pathway and to define the
molecular mechanisms that link cAMP activation to the actin
cytoskeleton. The findings also pose multiple questions regarding the downstream effects of cAMP signaling that ultimately
lead to HWP1 gene expression. Interruption of these processes
will ultimately lead to new strategies for disrupting the regu-
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latory circuits that connect morphogenesis to the expression of
virulence genes in C. albicans.
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